Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma.

Abstract excerpt

To compare costs of molecular and conventional screening of retinoblastoma relatives, we evaluated the direct health care costs. With variables set at the most likely values (baseline), the expected cost (in 1994 Canadian dollars) of conventional screening was $31,430 for a prototype family consisting of seven at-risk relatives (three clinic exams and eight examinations under anaesthetic over the first 3 years of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Electrocardiography
• Share to Genes, Retinoblastoma
• Share to Genetic Testing